N/A
20 Years
80 Years
20 Years
80 Years
Not Enrolling
Both
Cancer Patients
Both
Cancer Patients
Trial Information
Inclusion Criteria:
- age 20-80
- cancer patient
- patient whom receiving opioid treatment, any acute or chronic pain condition amenable
to a diagnostic/therapeutic nerve block or neuromodulation,and a regular analgesic
regimen.
Exclusion Criteria:
- patient who has any change in opioid or other analgesic medications less than 14 days
prior to the scheduled procedure
- an inability to understand English or adequately respond to the relevant questions
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
Post-injection pain intensity
Outcome Description:
The local anesthetic injection before main procedure was performed by one pain physician using a 25-gauge needle and 1 ml of 1% lidocaine to raise a small skin wheel. Before and immediately following the injection, patients were asked to rate injection-specific pain and unpleasantness intensity on a 0 to 10 numerical rating scale (NRS).
Outcome Time Frame:
1 min after lidocaine anesthetic injection
Safety Issue:
No
Authority:
South Korea: Institutional Review Board
Study ID:
4-2012-0066
NCT ID:
NCT01704469
Start Date:
March 2012
Completion Date:
September 2012
Related Keywords:
- Cancer Patients
- Opioid induced hyperalgesia
Name | Location |
|---|
